Evidence map›Paper›PMID 25579814›Full record

ArticleStructure (London, England : 1993)2015

Structural plasticity of methyllysine recognition by the tandem tudor domain of 53BP1.

Qiong Tong, Gaofeng Cui, Maria Victoria Botuyan, Scott B Rothbart, Ryo Hayashi, Catherine A Musselman, Namit Singh, Ettore Appella, Brian D Strahl, Georges Mer and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Targeting p53 pathways: mechanisms, structures, and advances in therapy.Signal transduction and targeted therapy · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. UVA irradiation strengthened an interaction between UBF1/2 proteins and H4K20 di-/tri-methylation.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2019
    Article
  12. Article
  13. Switching 53BP1 on and off via Tudors.Nature structural & molecular biology · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Reading chromatin signatures after DNA double-strand breaks.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Qiong TongDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Gaofeng CuiDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Maria Victoria BotuyanDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Scott B RothbartDepartment of Biochemistry and Biophysics and the Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Ryo HayashiLaboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Catherine A MusselmanDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Namit SinghDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Ettore AppellaLaboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Brian D StrahlDepartment of Biochemistry and Biophysics and the Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Georges MerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: mer.georges@mayo.edu.
Tatiana G KutateladzeDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: tatiana.kutateladze@ucdenver.edu.
University of Colorado Denver · USMayo Clinic · USNational Cancer Institute · USUNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · USWinnMed · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Targeted MV-CEA as a Potent Antitumor Agent against GBMP50CA108961 · NCI · MAYO CLINIC ROCHESTER · PI O'NEILL, BRIAN PATRICK · 2004 to 2015
$22.5M
Tumor Suppressor Protein, p53ZIABC005599 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI APPELLA, ETTORE · 2009 to 2025
$8.1M
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint SignalingR01CA132878 · NCI · MAYO CLINIC ROCHESTER · PI Georges Mer · 2008 to 2026
$4.5M
Molecular analysis of methylated p53R01GM101664 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2013 to 2016
$1.7M
Factors that regulate chromatin organization and gene transcriptionR01GM110058 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STRAHL, BRIAN D · 2014 to 2017
$1.2M
Mechanisms Regulating DNA Methylation Maintenance in ChromatinR00CA181343 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2015 to 2017
$746k
Mechanisms Regulating DNA Methylation Maintenance in ChromatinK99CA181343 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROTHBART, SCOTT · 2014 to 2015
$211k
Intramural NIH HHSNCI NIH HHS CA132878NCI NIH HHS CA181343NCI NIH HHS K99 CA181343NCI NIH HHS P30 CA046934NCI NIH HHS P50 CA108961NCI NIH HHS P50CA108961NCI NIH HHS P50 CA116201NCI NIH HHS P50CA116201NCI NIH HHS R00 CA181343NCI NIH HHS R01 CA132878NIGMS NIH HHS GM101664NIGMS NIH HHS GM110058NIGMS NIH HHS R01 GM101664NIGMS NIH HHS R01 GM110058
6 · The paper itself

Abstract

p53 is dynamically regulated through various posttranslational modifications (PTMs), which differentially modulate its function and stability. The dimethylated marks p53K370me2 and p53K382me2 are associated with p53 activation or stabilization and both are recognized by the tandem Tudor domain (TTD) of 53BP1, a p53 cofactor. Here we detail the molecular mechanisms for the recognition of p53K370me2 and p53K382me2 by 53BP1. The solution structures of TTD in complex with the p53K370me2 and p53K382me2 peptides show a remarkable plasticity of 53BP1 in accommodating these diverse dimethyllysine-containing sequences. We demonstrate that dimeric TTDs are capable of interacting with the two PTMs on a single p53K370me2K382me2 peptide, greatly strengthening the 53BP1-p53 interaction. Analysis of binding affinities of TTD toward methylated p53 and histones reveals strong preference of 53BP1 for p53K382me2, H4K20me2, and H3K36me2 and suggests a possible role of multivalent contacts of 53BP1 in p53 targeting to and accumulation at the sites of DNA damage.

Indexed as

Models, MolecularAmino Acid SequenceDNA MethylationHumansIntracellular Signaling Peptides and ProteinsLysineMagnetic Resonance SpectroscopyMolecular Sequence DataMultiprotein ComplexesProtein Structure, TertiaryTumor Suppressor p53-Binding Protein 1Intracellular Signaling Peptides and ProteinsLysineMultiprotein ComplexesTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID25579814
PMCPMC4321732
OpenAlexW2090450752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.